Quiz 1 Flashcards
1
Q
1st Generation Antipsychotics (FGA) classes
A
- Phenothiazines
- NonPhenothiazines
2
Q
Common side effects (nervous system)
A
1.EPS
2.Tardive Dyskinesia
3.Anticholinergic Side Effects
4.NMS
5.Sedation
6.Confusion
7.Headaches
8.Seizures
9.Sleep Disturbances
3
Q
1.Major components of EPS
A
- akathisia
- akinesia
- pseudo Parkinsonism
- dystonia
4
Q
What is EPS
A
group of motor disturbances caused by DOPAMINE being BLOCKED in NIGROSTRIATAL PATHWAY
5
Q
How can EPS be controlled
A
antiparkinson meds
6
Q
Akathisia
A
- onset 5-60 days from start
- improves with ⬇ in med or addition of BENZODIAZEPINE or PROPRANOLOL
7
Q
Akinesia/Bradykinesia
A
↑ dose = ↑ symptoms
8
Q
Pseudo Parkinsonism
A
- onset is 1st week after start
9
Q
Acute Dystonic Reactions
A
- onset is 1-5 days after start or increase
- respond well to anticholinergics - BENZTROPINE
10
Q
2.What is Tardive Dyskinesia
A
- onset occurs late in treatment
- most prominent with HIGH POTENCY & HIGH DOSES of TYPICAL antipsychotics
- believed cause is chronic exposure to DOPAMINE receptor BLOCKING agents in NIGROSTRIATAL PATHWAY
- usually IRREVERSIBLE WITH no EFFECTIVE TREATMENT
- AIMS scale
11
Q
- What are Anticholinergic Side Effects
A
- DOPAMINE BLOCKS CHOLINERGIC receptors in NIGROSTRIATAL PATHWAY
12
Q
- What is NMS
A
- onset occurs hrs-mo after start
- HYPOdopaminergic state (severe ↓ dopamine)
- risk factors: initiation, ↑, or use of multiple antipsychotic meds
- treatment: immediate discontinuation, prescribed dopamine AGONIST (BROMOCRIPTINE), supportive treatments
13
Q
- Seizures
A
- ↑ dose rapidly
14
Q
Common side effects (endocrine system)
A
- metabolism
- sexual hormone dysregulation
15
Q
- Metabolism
A
- OLANZAPINE, CLOZAPINE (WBC count) & QUETIAPINE have ↑ risk for metabolic side effects